Times Square Capital Management, LLC Gh Research PLC Transaction History

Times Square Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$10.15 - $16.15 $184,821 - $294,075	-18,209 Reduced 3.78%	463,600 $5.39 Million
Q2 2022 Aug 05, 2022	SELL	$8.99 - $19.87 $14,384 - $31,792	-1,600 Reduced 0.33%	481,809 $4.81 Million
Q1 2022 May 06, 2022	SELL	$15.48 - $23.98 $230,497 - $357,062	-14,890 Reduced 2.99%	483,409 $8.84 Million
Q4 2021 Feb 04, 2022	SELL	$14.1 - $27.9 $32,430 - $64,170	-2,300 Reduced 0.46%	498,299 $11.6 Million
Q3 2021 Nov 08, 2021	BUY	$16.51 - $23.68 $1.29 Million - $1.85 Million	78,310 Added 18.54%	500,599 $11 Million
Q2 2021 Aug 09, 2021	BUY	$19.25 - $21.73 $8.13 Million - $9.18 Million	422,289 New	422,289 $9.18 Million

27.8M

2.8K

3.8K

Ticker GHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,020,800
Market Cap $380M
Description
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.